CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Paris Saint-Germain head into the Champions League knockout phase in rude health, with their crushing domination against domestic opposition making a Ligue 1 and French Cup double look highly likely ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

Q4 2024 Management View CEO Soren Tulstrup highlighted full-year 2024 revenue of SEK 171.3 million, marking a 28% year-over-year increase, with IDEFIRIX product sales contributing SEK 140.1 million ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

Research shows that low protein intake is also a risk factor for bone injuries, such as stress fractures. One study on female ...

The Putnam County Regional Planning Commission will get their first look next week at the preliminary plans for an 87-lot ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

The phase 3 DELTA TEEN trial evaluating Anzupgo 20 mg/g cream for the treatment of chronic hand eczema in adolescents has shown positive results, LEO Pharma announced in a press release. The 16-week, ...

Vast Space has started testing a qualification model of its first commercial space station but has pushed back the launch of that station into 2026.

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...